23andMe Holding Co. (MEHCQ)
OTCMKTS · Delayed Price · Currency is USD
3.760
-0.040 (-1.05%)
Aug 15, 2025, 4:00 PM EDT

23andMe Holding Co. Company Description

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally.

The company provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.

It also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; offers non-controlled medications for treatment of acute and chronic conditions; and provides Ozempic and Wegovy through its weight loss program, offering consumers with access to affordable weight management care.

In addition, the company provides research services. 23andMe Holding Co. was founded in 2006 and is headquartered in San Francisco, California.

23andMe Holding Co.
CountryUnited States
Founded2006
IndustryDiagnostics & Research
SectorHealthcare
Employees265
CEOJoseph Selsavage

Contact Details

Address:
870 Market Street
San Francisco, Delaware 94102
United States
Phone(650) 938-6300
Website23andme.com

Stock Details

Ticker SymbolMEHCQ
ExchangeOTCMKTS
Share ClassClass A Shares
Fiscal YearApril - March
Reporting CurrencyUSD
SIC Code8071

Key Executives

NamePosition
Joseph Anthony SelsavageInterim Chief Executive Officer and Chief Financial and Accounting Officer
Anne WojcickiCo-Founder and Director
Matthew E. KvardaChief Restructuring Officer
Guy ChayounVice President, General Counsel and Corporate Secretary
Tracy KeimChief Marketing Officer
Savita PillaiVice President of People
Daniel ChuChief Product Officer
Frank RussoChief Security Officer
Kent HillyerVice President of Consumer Operations
Adam Auton Ph.D.Vice President of Human Genetics